Integra Lifesciences Holdings (IART) Inventory Average (2010 - 2026)

Integra Lifesciences Holdings' Inventory Average history runs 17 years deep, the most recent figure standing at $493.9 million for Q1 2026.

• In Q1 2026, Inventory Average rose 12.95% year-over-year to $493.9 million; the TTM figure through Mar 2026 stood at $493.9 million (up 12.95% YoY), while the FY2025 annual figure was $460.9 million, up 12.6% from the prior year.
• Inventory Average came in at $493.9 million for Q1 2026 at Integra Lifesciences Holdings, up from $490.9 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $493.9 million in Q1 2026 to a low of $315.6 million in Q3 2022.
• A 5-year average of $396.2 million and a median of $396.5 million in 2024 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average fell 3.0% in 2022 and advanced 19.17% in 2024, its largest moves.
• Integra Lifesciences Holdings' Inventory Average stood at $317.8 million in 2022, then climbed by 18.91% to $377.9 million in 2023, then grew by 14.57% to $433.0 million in 2024, then gained by 13.37% to $490.9 million in 2025, then climbed by 0.6% to $493.9 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $493.9 million, $490.9 million, and $477.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison